Barclays Downgrades Pfizer (PFE) to Equalweight
Tweet
Share
E-mailGet Alerts PFE Hot Sheet
Price: $21.68 +1.03%
Rating Summary:
12 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Rating Summary:
12 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Join SI Premium – FREE
Barclays downgraded Pfizer (NYSE: PFE) from Overweight to Equalweight.
For more ratings news on Pfizer click here and for the rating history of Pfizer click here.
Shares of Pfizer closed at $18.33 yesterday.
For more ratings news on Pfizer click here and for the rating history of Pfizer click here.
Shares of Pfizer closed at $18.33 yesterday.
Create E-mail Alert Related Categories
Downgrades, Hot DowngradesRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
